Comments on: Limitations of HPV DNA Testing in Screening of Cervical Adenocarcinomas

CC BY 4.0 · Rev Bras Ginecol Obstet 2019; 41(02): 133-134
DOI: 10.1055/s-0039-1678591

Letter to the Editor

Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

¹Lâmina Laboratory of Pathology and Cancer Prevention, Brasília, DF, Brazil

References
1 Zeferino LC, Bastos JB, Vale DBAPD. , et al. Guidelines for HPV-DNA testing for cervical cancer screening in Brazil. Rev Bras Ginecol Obstet 2018; 40 (06) 360-368 Doi: 10.1055/s-0038-1657754
2 de Sanjose S, Quint WG, Alemany L. , et al; Retrospective International Survey and HPV Time Trends Study Group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010; 11 (11) 1048-1056 Doi: 10.1016/S1470-2045(10)70230-8
3 Stolnicu S, Barsan I, Hoang L. , et al. International Endocervical Adenocarcinoma Criteria and Classification (IECC): a new pathogenetic classification for invasive adenocarcinomas of the endocervix. Am J Surg Pathol 2018; 42 (02) 214-226 Doi: 10.1097/PAS.0000000000000986
4 Nanda K, McCrory DC, Myers ER. , et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000; 132 (10) 810-819 Doi: 10.7326/0003-4819-132-10-200005160-00009
5 Cuzick J, Clavel C, Petry KU. , et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006; 119 (05) 1095-1101

References
1 de Sanjose S, Quint WG, Alemany L. , et al; Retrospective International Survey and HPV Time Trends Study Group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010; 11 (11) 1048-1056 Doi: 10.1016/S1470-2045(10)70230-8
2 Bucchi L, Baldacchini F, Mancini S. , et al. Estimating the impact of an organised screening programme on cervical cancer incidence: a 26-year study from northern Italy. Int J Cancer 2018 •••;. Doi: 10.1002/ijc.31806
3 Stolnicu S, Barsan I, Hoang L. , et al. International Endocervical Adenocarcinoma Criteria and Classification (IECC): a new pathogenetic classification for invasive adenocarcinomas of the endocervix. Am J Surg Pathol 2018; 42 (02) 214-226 Doi: 10.1097/PAS.0000000000000986
4 Ronco G, Dillner J, Elfström KM. , et al; International HPV screening working group. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 2014; 383 (9916): 524-532 Doi: 10.1016/S0140-6736(13)62218-7
5 Andrae B, Kemetli L, Sparén P. , et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008; 100 (09) 622-629 Doi: 10.1093/jnci/djn099